Clinical Updates & Insights

Our clinical updates provide you with timely information about Memorial Sloan Kettering’s new treatment approaches, key clinical trials, and innovations in detecting and treating many cancers.

Stay Informed
Get the latest information on MSK’s cancer treatments and research sent straight to your inbox with our monthly clinical updates e-newsletter OncoNotes.
Newsletter Sign Up
229 Clinical Updates found
Vivian E. Strong, MD, FACS
Gastrectomy Better than Surveillance for Patients with Stomach Cancer Gene

Our recent research confirms that total gastrectomy should be considered for all patients with the CDH1 gene mutation that carries a high risk for developing hereditary diffuse gastric cancer.
Anita Kumar, MD, speaks to a patient
Changing the Therapeutic Landscape for Patients with Mantle Cell Lymphoma

There is no established standard therapy for the treatment of mantle cell lymphoma (MCL). Instead, there is a range of treatment options and, to date, there has been a dearth of data to assist in clinical decision-making.
MSK radiology tech
Contrast-Enhanced Digital Mammograms: An Effective Alternative to MRI

Recent research from Memorial Sloan Kettering shows that dual-energy contrast-enhanced digital mammography (CEDM) is as sensitive in detecting breast cancer as contrast-enhanced breast MRI when both were compared with standard mammograms.
MSK breast medical oncologist Shari Goldfarb
Improving Women’s Sexual Health after Cancer Treatment

Our research shows that most women diagnosed with either breast or gynecologic cancer have concerns about how treatment may affect their sexual and vaginal health. Moreover, they want their healthcare providers to initiate the discussion.
MSK breast cancer patient Elizabeth Shelley
Individualized Approach Enables De-escalation of Breast Cancer Treatment: A Clinical Case History

Advances in our understanding of the biology of breast cancer are guiding the development of individualized treatment plans. We outline the clinical case history of young breast cancer patient, Elizabeth Shelley, including our rational for not proceeding with the originally prescribed chemotherapy.
MSK Surgeon Alvin C. Goh, MD
Minimally Invasive Cystectomy and Bladder Reconstruction in One Operation

Performing minimally invasive robotic cystectomy and bladder reconstruction in one operation provides a viable alternative to open surgery with less blood loss, decreased pain, diminished wound morbidity, and the potential for faster return of bowel function.
Elizabeth Morris
Second Opinion Following Routine Breast Imaging Supports Diagnostic Accuracy

Recent data from Memorial Sloan Kettering shows that a real-time breast ultrasound exam after second opinion review of outside, static breast ultrasound images led to a change in the initially prescribed management in 32.5 percent of included patients.
MSK lab tests
Active Surveillance of Prostate Cancer: Advances for More-Accurate Risk Assessment

Active surveillance of prostate cancer is being increasingly utilized for men with low-risk cancer. But some men with potentially life-threatening cancers are being inadvertently enrolled in such programs, driving the need for more accurate decision-making tools such as the 4Kscore test developed at Memorial Sloan Kettering.
Data Proves a Significant Survival Advantage with Hepatic Arterial Infusion in Metastatic Colorectal Cancer
Data Proves a Significant Survival Advantage with Hepatic Arterial Infusion in Metastatic Colorectal Cancer

Hepatic arterial infusion chemotherapy given to colorectal cancer patients with liver metastases extends their survival by almost two years, according to a large retrospective study from Memorial Sloan Kettering recently published in the JCO.
Active Monitoring of Papillary Thyroid Cancer

American Thyroid Association guidelines endorse close observation as a treatment option for many small papillary thyroid tumors rather than surgery. MSK endocrinologist Michael Tuttle MD discusses why monitoring such cancers is a viable approach.